A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency

  1. Santamaria, M.
  2. Neth, O.
  3. Douglass, J.A.
  4. Krivan, G.
  5. Kobbe, R.
  6. Bernatowska, E.
  7. Grigoriadou, S.
  8. Bethune, C.
  9. Chandra, A.
  10. Horneff, G.
  11. Borte, M.
  12. Sonnenschein, A.
  13. Kralickova, P.
  14. Ramón, S.S.
  15. Langguth, D.
  16. Gonzalez-Granado, L.I.
  17. Alsina, L.
  18. Querolt, M.
  19. Griffin, R.
  20. Hames, C.
  21. Mondou, E.
  22. Price, J.
  23. Sanz, A.
  24. Lin, J.
Journal:
Journal of Clinical Immunology

ISSN: 1573-2592 0271-9142

Year of publication: 2022

Volume: 42

Issue: 3

Pages: 500-511

Type: Article

DOI: 10.1007/S10875-021-01181-6 GOOGLE SCHOLAR lock_openOpen access editor